Background: Ankle-brachial pressure index (ABI) is an independent predictor of the extent of coronary atherosclerosis and cardiovascular events. To date ABI measurement is not part of the routine examination in patient admitted for coronary angiography. Our objective was to establish ABI measurement as a routine procedure in our interventional cardiology unit to ameliorate the assessment of coronary risk level for patients admitted for scheduled coronary angiography.
Results:
In the pilot study, 40 consecutive patients were included between February and April 2009. 79% were males and the mean age was 66+/-12 years. ABI < 0.9 was found in 6 patients. Significant multivessel disease was found in 10 patients: 6 with ABI<0.9 and 4 with ABI≥0.9. Patients with ABI<0.9 were significantly older 75+/-11 vs 64+/-12 (p=0.04) and had a trend for lower glomerular filtration rate MDRD=61+/-21 vs 77+/-20 mL/min/1.73m_ (p=0.08). 5years probability of cardiovascular death was 12+/-7.4% in patients with ABI<0.9 vs 7.2+/-7.6 in patients with ABI≥0.9 (p=ns). Multivariate analysis showed that ABI remains a significant predictor of multivessel disease after adjustment on other risk factors. Low ABI was significantly correlated with 5 years probability of cardiovascular death (spearman = -0.36, P=0.03).
Conclusion: ABI was an independent predictor of coronary multivessel disease and 5 years probability of cardiovascular death. Routine ABI measurement in patients with known or suspected coronary artery disease provides additional information regarding patient's risk and may be taken into account to establish optimal care strategy.
Natural History Of Dual Anti-Platelet Responsiveness After Angioplasty In Elderly Patients
A M Tidjane (1), R Ghenim (1), V. Bongard (1), Nicolas Boudou (1), Nicolas Dumonteil (1), N. Hammami (1), Abdelkader Ziani (1), S Voisin (2), Th Lhermusier (1), P Sié (2), Didier Carrié (1) (1) CHU Rangueil, Cardiovascular and Metabolic Pole, Toulouse, France -(2) CHU Rangueil, Hemostasis Laboratory, Toulouse, France Background: Dual antiplatelet therapy with aspirin (Asa) and clopidogrel (Clopi) is the cornerstone of treatment for patients (pts) after angioplasty (PCI). The state of dual antiplatelet responsiveness is not well known especially in elderly pts.
Objectives:
The aim of this monocentric prospective observational study is to evaluate Asa and Clopi activity after PCI in elderly pts and to asses the evolution of this responsiveness at 5 weeks.
Methods:
We enrolled 81 elderly pts (≥75 years) from Jan to Dec 2008 on Asa (75 mg/day ≥ 7 days) and Clopi (after loading dose 300 mg before PCI and 150mg /day for 4 weeks fellowed by 75 mg/ day for 1 year). We used the VerifyNow Asa assay and the VerifyNow Clopi P2Y12 assay (Accumetrics Inc, USA) to determinate respectively Asa and Clopi responsiveness in-hospital at 11.30 am (T1) and during a medical consultation at 5 weeks (T2).
Results:
Asa non responders were noted in 10% and in 14% pts at respectively T1 and T2, Clopi non responders in 37% and in 70% pts at respectively T1 and T2. Significant changes were observed in Clopi response from responder to non responder (p < 0.001); similarly changes were noticed but in both ways for Asa response from T1 to T2 (p=0.005). Mutivariate analysis revelead plasma-HDL-cholesterol (OR [0.81]; 95% CI[0.67 to 0.98];p=0.031; for a raising of 0.1 mmol/L) and hematocrit level (OR [0.85]; 95% CI [0.75 to 0.96]; p=0.008 for an increasing of 1%) to be independent predictors of Clopi non responsiveness at T1; in the same way diabetes (OR [0.30]; 95% CI [0.10 to 0.95]; p=0.041; for non diabetes vs diabetes) and hematocrit level (OR [0.8]; 95% CI [0.77 to 1.00]; p=0.045 for an increasing of 1%) are independtly associated with Clopi non responsiveness at T2.
Conclusions:
In elderly, after PCI, there are changes in dual antiplatelet responsiveness between tests in-hospital and at 5 weeks marked for Clopi activity. Low hematocrit remains an independent predictor of Clopi non responsiveness.
Predictive factors of ST-segment resolution after primary angioplasty and clinical outcome
Khaldoun Ben Hamda, Feriel Moatemri, Hichem Denguir, Sonia Hamdi, Mohamed Amine Majdoub, Sabri Maaoui, Hamza Thawaba, Faouzi Maatouk CHU de Monastir, Service de Cardiologie, Monastir, Tunisie
In the setting of acute myocardial infarction (AMI), early resolution of STsegment elevation was a useful predictor of final infarct size, left ventricular function and clinical outcome.
Aim: to determine the predictive factors of ST-segment resolution immediately following primary coronary angioplasty for AMI.
Methods: primary angioplasty was performed in 270 consecutive patients with first AMI, they were divided into 2 groups according to whether ST-segment resolution occurred 1 hour after the procedure. ST-segment resolution ≥ 70% was considered as 'complete' ST-segment resolution, whereas ST-segment resolution < 70% was considered as 'incomplete' ST-segment resolution.
Results: of the 270 patients, 156 (57.8%) had complete ST-segment resolution. Patients with pre-infarction angina had a greater degree of ST-segment resolution than those without angina (71 ±21 % vs. 49± 43%, p<0.02).
On multivariate analysis, the absence of pre-infarction angina (OR=2.7; CI 1.7-3.4,p=0.03) as well as the admission after H4 (OR=3.5; CI 1.58-8.06, p=0.002), patient age ≥ 70 year(OR= 5.6; CI 2.23-14.4,p<0.001) and initial TIMI flow grade 0/1 (OR=13.6; CI 4.5-21.2, p<0.001) were major independent predictors of poor ST-segment resolution; whereas sex, coronary risk factors, killip class on admission, multivessel disease and extent of collaterals were not significant.
There was a significant difference in survival free of major adverse cardiovascular events, at multivariate analysis =, incomplete ST-segment resolution was an independent factor of 1-year mortality (p=0.016).
Conclusions:
Rapid ST-segment resolution was associated with a better clinical outcome and prognosis after successful primary PTCA. Pre-infarction angina, age < 70 years, TIMI flow 2/3 and ischemia time < 4 hours were associated with a greater degree of ST-segment resolution after primary angioplasty.
C-Reactive Protein Improves Risk Prediction in Patients with Acute Coronary Syndromes
Francois Schiele, Nicolas Meneveau, Marie-France Seronde, Vincent Descotes-Genon, Romain Chopard, Joanna Oettinger, Alexandre Guignier, Florant Briand, Jean-Pierre Bassand CHU Besancon, Cardiologie, Besancon, France Rationale and aim: Elevated C-reactive protein level is a risk marker in patients with acute coronary syndromes (ACS), but current risk score systems do not consider this factor. We studied the incremental predictive value of adding CRP to the GRACE risk score.
Methods and results:
Characteristics, treatments and 30-day mortality were recorded for 1408/1901 consecutive ACS patients. Changes in global model fit, discrimination, calibration and reclassification were evaluated upon addition of CRP to the GRACE risk score. High-CRP patients (CRP >22 mg/L, 4 th quartile of CRP) were older, had more comorbidities and worse hemodynamic conditions, received less recommended treatment and had a four-fold higher 30 day mortality. Multivariable analysis demonstrated high-CRP as an important and independent predictor of mortality. Addition of high-CRP in the GRACE model improved global fit, discriminatory capacity and calibration. Patients were divided into 4 groups according to GRACE risk score prediction: <1%, 1 to <5%, 5 to <10% and >=10%. The model with high-CRP allowed adequate reclassification in 12.2%.
Conclusions:
Elevated CRP level is an independent and important predictive factor of 30-day mortality in ACS patients, even after adjustment for comorbidities, hemodynamic conditions and treatment. Combined with the GRACE risk score, CRP information improves risk classification.
Coronary angioplasty of the chronic total occlusion. Outcome and study of the Balance Risc and Benefit. A study of 62 cases

Kais Battikh, Maher Souissi, M Lotfi Slimane CHU Habib Thameur Tunis, Cardiologie, Tunis, Tunisie
Percutaneous coronary intervention (PCI) of the coronary chronic total occlusion (CTO) is widely discussed because of the difficulty and the risks of the procedure and the controversial but very interesting clinical benefit in case of procedure success.
Objective: To evaluate the in-hospital and long-term clinical outcome of PCI in the case of CTO and measure the adverse effects and complications.
Methods: 62 cases of PCI for a CTO were consecutively registered from January 2005 to February 2009. In addition to an assessment of the technical characteristics and procedural outcomes, patients were followed for occurrence of major adverse cardiac events (MACE). These patients are distributed in two groups: (A) for the occlusion between 1 and 3 months age and (B) for the occlusion of more than 3 months age. RESULTS: 68 lesions were treated in these 62 patients (47 male and 15 female) with mean age of 59 years (40-80). 42% of theses patients were diabetics, 48% smoker and 26% with hypertension. 27 patients had an ST elevation acute coronary syndrome (ACS) and 24 a non ST elevation ACS, where 2 had stable angina. Balloon angioplasty was performed in only 4 cases and the stenting in 58 cases with use of 64 stents (average of 1.1 stent / artery and of 1.2 stent / patient), we used drug eluting stent in only 10 case (15.6 %). Total procedure success rate, defined by a patent artery (less then 30% residual stenosis) with TIMI 3 flow (grade 3) at the end of the PCI was 83 %( 57/68) . The success was better in the group A 90% (29/32) then the group B 77% (28/36) (P < 0.05). The most frequent cause of procedure failures was unsuccessful crossing with the wire in 6 cases and no severe acute complications were done. Theses CTO required long procedures with an average time of fluoroscopy of 30 ' 13 ", an average calculated dose radiation DAP of 20611 cGy / cm2 and a high mean amount of contrast media 289.46 ml. At the preliminary clinical results, patients with successful PCI of a CTO had a significantly better clinical outcome than those whose PCI was unsuccessful.
048
Does heart rate predict coronary allograft vasculopathy and coronary events in heart transplant recipients?
Pierre Ambrosi (1), Gilbert Habib (1), Bernard Kreitmann (2) (1) Hôpital de la Timone, Service de Cardiologie, Marseille, France -(2) Hôpital de la Timone, Chirurgie cardiaque, Marseille, France
Previous studies have shown that heart rate is a predictor of coronary events and cardiovascular mortality. Moreover, pathophysiological studies indicate that a relatively high heart rate has detrimental effects on the progression of coronary atherosclerosis. Heart transplant recipients frequently have sinus tachycardia related to cardiac denervation. Therefore we evaluated the prognostic importance of heart rate in heart transplant recipients. 143 consecutive heart transplant recipients (age at transplantation: 48.5±13 years) with at least a 2 year survival after transplantation were studied with a 9.5 year mean follow-up (range 2-23 years). Basal heart rate was measured at rest 3 months after heart transplantation in the absence of beta-blocker therapy or acute rejection. Survival without cardiac event was compared between patients with basal heart rate < or >95/min (median) according to Kaplan-Meier method using log-rank test.
Fifty-six patients had coronary irregularities or stenoses at routine biennal coronary angiography and 87 had angiographically normal coronary arteries during the follow-up. Mean basal heart rate did not significantly differ between these two groups (96.4/min vs 98.3/min p=0.34). Twenty-seven patients had a coronary event (myocardial infarction, percutaneous coronary intervention or coronary death). Survival without coronary event did not significantly differ between patients with basal heart rate > or < 95/min (logrank p= 0,97).
